Cargando…
Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort
BACKGROUND: Myasthenia gravis (MG) patients are reported to have a high risk of other autoimmune diseases (ADs), and thymectomy may increase the risk further. A cohort of MG patients in which thymectomy was performed were investigated to analyze the prevalence, types and features of the new onset AD...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834700/ https://www.ncbi.nlm.nih.gov/pubmed/36419347 http://dx.doi.org/10.1111/1759-7714.14723 |
_version_ | 1784868518675611648 |
---|---|
author | Tian, Wenxin He, Jing Yu, Hanbo Sun, Yaoguang Wu, Qingjun Jiao, Peng Ma, Chao Huang, Chuan Li, Donghang Tong, Hongfeng |
author_facet | Tian, Wenxin He, Jing Yu, Hanbo Sun, Yaoguang Wu, Qingjun Jiao, Peng Ma, Chao Huang, Chuan Li, Donghang Tong, Hongfeng |
author_sort | Tian, Wenxin |
collection | PubMed |
description | BACKGROUND: Myasthenia gravis (MG) patients are reported to have a high risk of other autoimmune diseases (ADs), and thymectomy may increase the risk further. A cohort of MG patients in which thymectomy was performed were investigated to analyze the prevalence, types and features of the new onset ADs. METHODS: Consecutive patients with MG who underwent thymectomy at Beijing Hospital between January 2012 and August 2021 were retrospectively enrolled. Patients with a postoperative follow‐up period shorter than a year or incomplete clinical records were excluded. Clinical and follow‐up data were collected. Statistical analyses were performed using SPSS version 22.0. RESULTS: A total of 445 patients were included in this study. The median follow‐up period was 72 months (range, 12–135 months). A total of 63 (14.2%) MG patients had concurrent ADs. The incidence rate was higher than the background prevalence of population (5%), and also higher than that of a former Chinese MG cohort (11.6%). A total of 47 patients (10.6%) were diagnosed with ADs before thymectomy, and 19 (4.3%) developed a new AD after thymectomy. The most common types of new onset ADs after thymectomy were Hashimoto's thyroiditis and rheumatoid arthritis (RA), which were different from those before thymectomy (hyperthyroidism and Hashimoto's thyroiditis). The incidence rate of new onset RA (1.35%) was higher than the frequency of RA before thymectomy (0.45%), and also higher than the incidence rate in a Chinese MG cohort (0.5%). There was a higher proportion of female patients (p = 0.026) with postoperative ADs. A younger age at operation may increase the risk of nonthymoma MG patients (p = 0.040) developing ADs. The postoperative treatment effect of MG was similar between patients with and without new onset ADs (p > 0.05). CONCLUSIONS: We observed a higher incidence rate of autoimmune diseases, especially rheumatoid arthritis, in MG patients after thymectomy. The most common types of ADs after thymectomy were different from those before thymectomy. New onset ADs tended to occur in female and young nonthymoma MG patients. The postoperative effect of MG was not related with the new occurrence of ADs. |
format | Online Article Text |
id | pubmed-9834700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-98347002023-01-17 Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort Tian, Wenxin He, Jing Yu, Hanbo Sun, Yaoguang Wu, Qingjun Jiao, Peng Ma, Chao Huang, Chuan Li, Donghang Tong, Hongfeng Thorac Cancer Original Articles BACKGROUND: Myasthenia gravis (MG) patients are reported to have a high risk of other autoimmune diseases (ADs), and thymectomy may increase the risk further. A cohort of MG patients in which thymectomy was performed were investigated to analyze the prevalence, types and features of the new onset ADs. METHODS: Consecutive patients with MG who underwent thymectomy at Beijing Hospital between January 2012 and August 2021 were retrospectively enrolled. Patients with a postoperative follow‐up period shorter than a year or incomplete clinical records were excluded. Clinical and follow‐up data were collected. Statistical analyses were performed using SPSS version 22.0. RESULTS: A total of 445 patients were included in this study. The median follow‐up period was 72 months (range, 12–135 months). A total of 63 (14.2%) MG patients had concurrent ADs. The incidence rate was higher than the background prevalence of population (5%), and also higher than that of a former Chinese MG cohort (11.6%). A total of 47 patients (10.6%) were diagnosed with ADs before thymectomy, and 19 (4.3%) developed a new AD after thymectomy. The most common types of new onset ADs after thymectomy were Hashimoto's thyroiditis and rheumatoid arthritis (RA), which were different from those before thymectomy (hyperthyroidism and Hashimoto's thyroiditis). The incidence rate of new onset RA (1.35%) was higher than the frequency of RA before thymectomy (0.45%), and also higher than the incidence rate in a Chinese MG cohort (0.5%). There was a higher proportion of female patients (p = 0.026) with postoperative ADs. A younger age at operation may increase the risk of nonthymoma MG patients (p = 0.040) developing ADs. The postoperative treatment effect of MG was similar between patients with and without new onset ADs (p > 0.05). CONCLUSIONS: We observed a higher incidence rate of autoimmune diseases, especially rheumatoid arthritis, in MG patients after thymectomy. The most common types of ADs after thymectomy were different from those before thymectomy. New onset ADs tended to occur in female and young nonthymoma MG patients. The postoperative effect of MG was not related with the new occurrence of ADs. John Wiley & Sons Australia, Ltd 2022-11-23 /pmc/articles/PMC9834700/ /pubmed/36419347 http://dx.doi.org/10.1111/1759-7714.14723 Text en © 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Tian, Wenxin He, Jing Yu, Hanbo Sun, Yaoguang Wu, Qingjun Jiao, Peng Ma, Chao Huang, Chuan Li, Donghang Tong, Hongfeng Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort |
title | Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort |
title_full | Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort |
title_fullStr | Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort |
title_full_unstemmed | Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort |
title_short | Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort |
title_sort | clinical characteristics of myasthenia gravis (mg) patients developing other autoimmune diseases after thymectomy from one single center cohort |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834700/ https://www.ncbi.nlm.nih.gov/pubmed/36419347 http://dx.doi.org/10.1111/1759-7714.14723 |
work_keys_str_mv | AT tianwenxin clinicalcharacteristicsofmyastheniagravismgpatientsdevelopingotherautoimmunediseasesafterthymectomyfromonesinglecentercohort AT hejing clinicalcharacteristicsofmyastheniagravismgpatientsdevelopingotherautoimmunediseasesafterthymectomyfromonesinglecentercohort AT yuhanbo clinicalcharacteristicsofmyastheniagravismgpatientsdevelopingotherautoimmunediseasesafterthymectomyfromonesinglecentercohort AT sunyaoguang clinicalcharacteristicsofmyastheniagravismgpatientsdevelopingotherautoimmunediseasesafterthymectomyfromonesinglecentercohort AT wuqingjun clinicalcharacteristicsofmyastheniagravismgpatientsdevelopingotherautoimmunediseasesafterthymectomyfromonesinglecentercohort AT jiaopeng clinicalcharacteristicsofmyastheniagravismgpatientsdevelopingotherautoimmunediseasesafterthymectomyfromonesinglecentercohort AT machao clinicalcharacteristicsofmyastheniagravismgpatientsdevelopingotherautoimmunediseasesafterthymectomyfromonesinglecentercohort AT huangchuan clinicalcharacteristicsofmyastheniagravismgpatientsdevelopingotherautoimmunediseasesafterthymectomyfromonesinglecentercohort AT lidonghang clinicalcharacteristicsofmyastheniagravismgpatientsdevelopingotherautoimmunediseasesafterthymectomyfromonesinglecentercohort AT tonghongfeng clinicalcharacteristicsofmyastheniagravismgpatientsdevelopingotherautoimmunediseasesafterthymectomyfromonesinglecentercohort |